Helaina

Helaina

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.myhelaina.com

Last Round

Series B

Sep 25, 2024

Est. Valuation

$65M

Total Funding Raised

$69M

Company Overview

Helaina is a food technology company that produces milk-equivalent baby formula using bioactive proteins from fermentation to provide immune-nourishing alternatives to breast milk.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

precision fermentationhuman lactoferrinbioactive proteinsB2B ingredientsynthetic biologyfood techhuman milk proteinsbreast milk startupfunctional food ingredientinfant nutritioninfant formulaimmune supportiron regulationmicrobiome healthyeast fermentation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Helaina Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Helaina Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BSep 25, 2024
Series ANov 19, 2021
SeedAug 31, 2020

Key People

Founding team and executive leadership

Laura Katz

Founder CEO

Founding Team

Anthony Clark

Chief Technology Officer

Executive Team

Helaina Investors

Notable investors and investment history

InvestorRounds
Siam CapitalSeries A, Series B
Relish WorksSeries B
Plum Alley InvestmentsSeries A
Avidity PartnersSeries B
Spark CapitalSeries B, Series A
Ingeborg InvestmentsSeries B
CF Private EquitySeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Effera™, an identical replica of human lactoferrin, has been launched.

Helaina Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Helaina Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Helaina's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range51
Year Founded2019
Last FundingSep 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.